{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T23:47:28Z","timestamp":1724543248373},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/mjt.0b013e31814b17bf","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:29:24Z","timestamp":1242919764000},"page":"164-170","source":"Crossref","is-referenced-by-count":14,"title":["Targeting the Inflammatory Response in Secondary Stroke Prevention: A Role for Combining Aspirin and Extended-release Dipyridamole"],"prefix":"10.1097","volume":"16","author":[{"given":"Andrew S","family":"Weyrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine J","family":"Skalabrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry W","family":"Kraiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210202","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","article-title":"American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. A statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke. Co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.STR.32.1.280","article-title":"Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association.","volume":"32","author":"Goldstein","year":"2001","journal-title":"Stroke"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R8-10-20210202","first-page":"CD001820","article-title":"Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.","volume":"19","author":"De Schryver","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0091270005276738","article-title":"Dipyridamole bioavailability in subjects with reduced gastric acidity.","volume":"45","author":"Derendorf","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial.","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2004.05.011","article-title":"Dipyridamole and headache-a pilot study of initial dose titration.","volume":"223","author":"Lindgren","year":"2004","journal-title":"J Neurol Sci"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2125.1999.00072.x","article-title":"Rapid development of tolerance to dipyridamole-associated headaches.","volume":"48","author":"Theis","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease.","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries.","volume":"316","author":"Glagov","year":"1987","journal-title":"N Engl J Med"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","article-title":"Experimental stroke induces massive, rapid activation of the peripheral immune system.","volume":"26","author":"Offner","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2005.11.032","article-title":"Inflammatory markers and in-hospital mortality in acute ischaemic stroke.","volume":"189","author":"Rallidis","year":"2006","journal-title":"Atherosclerosis"},{"key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.STR.0000181754.38408.4c","article-title":"Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.","volume":"36","author":"Woodward","year":"2005","journal-title":"Stroke"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5551\/jat.12.185","article-title":"Relevance of platelet-independent effects of aspirin to its salutary effect in atherosclerosis-related events.","volume":"12","author":"Khan","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1165\/ajrcmb\/9.2.179","article-title":"Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b\/CD18) expression on FMLP-stimulated neutrophils.","volume":"9","author":"Wollner","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R23-10-20210202","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0003-4975(99)00173-3","article-title":"Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery.","volume":"67","author":"Chello","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.CIR.0000154607.90506.45","article-title":"Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates.","volume":"111","author":"Weyrich","year":"2005","journal-title":"Circulation"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease.","volume":"95","author":"Charo","year":"2004","journal-title":"Circ Res"},{"key":"R26-10-20210202","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jvs.2005.08.009","article-title":"Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients.","volume":"42","author":"Verhoeven","year":"2005","journal-title":"J Vasc Surg"},{"key":"R27-10-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09537100500235966","article-title":"Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.","volume":"17","author":"Zhao","year":"2006","journal-title":"Platelets"},{"key":"R28-10-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.mbc.0000198050.27387.ea","article-title":"Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events.","volume":"17","author":"Rogowski","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R29-10-20210202","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.","volume":"37","author":"Feldman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R30-10-20210202","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","article-title":"Steering Committee and PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively avoiding Second Strokes (PRoFESS) Trial.","volume":"23","author":"Diener","year":"2007","journal-title":"Cerebrovasc Dis"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-200903000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:23Z","timestamp":1618036763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200903000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31814b17bf","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}